摘要 |
The present invention relates to antibodies directed against Respiratory Syncytial Virus (RSV), and hybridoma lines which produce them (e.g., HNK20). The antibodies can be used for the prevention or treatment of RSV infection and disease, as well as employed in methods for diagnosing RSV infection.
|